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Introduction {#jdi12612-sec-0005}
============

Gestational diabetes mellitus (GDM), defined as impaired glucose tolerance with onset or first identification during pregnancy, is one of the most frequent complications of pregnancy. The prevalence is estimated to be 5--10%, and the incidence rate has shown a gradual upward trend[1](#jdi12612-bib-0001){ref-type="ref"}, [2](#jdi12612-bib-0002){ref-type="ref"}, making it a growing health issue[3](#jdi12612-bib-0003){ref-type="ref"}. GDM increases the risk of adverse pregnancy outcomes, and has adverse effects for both mothers and their children, including susceptibility to obesity, metabolic syndrome and type 2 diabetes mellitus in later life[3](#jdi12612-bib-0003){ref-type="ref"}, [4](#jdi12612-bib-0004){ref-type="ref"}, [5](#jdi12612-bib-0005){ref-type="ref"}. Furthermore, GDM occurrence is confused in different populations or ethnic groups. Therefore, it is necessary to systematically evaluate *TCF7L2* gene polymorphisms and GDM susceptibility in all population and racial/ethnic subgroups.

GDM is a heterogeneous metabolic disorder, with mixed genetic etiology and phenotypes[6](#jdi12612-bib-0006){ref-type="ref"}. Insulin resistance is regarded as an important factor to contribute to GDM. Furthermore, there are heritable elements, and GDM could share some risk factors of genetics with type 2 diabetes mellitus[7](#jdi12612-bib-0007){ref-type="ref"}. Transcription factor 7‐like 2 (*TCF7L2*) expresses in pancreatic β‐cells[8](#jdi12612-bib-0008){ref-type="ref"}, and belongs to the high mobility group‐box family as a transcription factor[9](#jdi12612-bib-0009){ref-type="ref"} that plays a crucial role in the maintenance of glucose homeostasis. Recent findings suggest that the *TCF7L2* contributes to GDM risk[10](#jdi12612-bib-0010){ref-type="ref"}.

So far, *TCF7L2* has multiple single nucleotide polymorphisms (SNPs), eight of which have been reported, including rs7903146[11](#jdi12612-bib-0011){ref-type="ref"}, [12](#jdi12612-bib-0012){ref-type="ref"}, [13](#jdi12612-bib-0013){ref-type="ref"}, [14](#jdi12612-bib-0014){ref-type="ref"}, [15](#jdi12612-bib-0015){ref-type="ref"}, [16](#jdi12612-bib-0016){ref-type="ref"}, [17](#jdi12612-bib-0017){ref-type="ref"}, [18](#jdi12612-bib-0018){ref-type="ref"}, [19](#jdi12612-bib-0019){ref-type="ref"}, [20](#jdi12612-bib-0020){ref-type="ref"}, [21](#jdi12612-bib-0021){ref-type="ref"}, [22](#jdi12612-bib-0022){ref-type="ref"}, [23](#jdi12612-bib-0023){ref-type="ref"}, [24](#jdi12612-bib-0024){ref-type="ref"}, [25](#jdi12612-bib-0025){ref-type="ref"}, [26](#jdi12612-bib-0026){ref-type="ref"}, [27](#jdi12612-bib-0027){ref-type="ref"}, [28](#jdi12612-bib-0028){ref-type="ref"}; rs12255372[16](#jdi12612-bib-0016){ref-type="ref"}, [17](#jdi12612-bib-0017){ref-type="ref"}, [18](#jdi12612-bib-0018){ref-type="ref"}, [19](#jdi12612-bib-0019){ref-type="ref"}, [20](#jdi12612-bib-0020){ref-type="ref"}, [21](#jdi12612-bib-0021){ref-type="ref"}, [26](#jdi12612-bib-0026){ref-type="ref"}, [28](#jdi12612-bib-0028){ref-type="ref"}, [29](#jdi12612-bib-0029){ref-type="ref"}, [30](#jdi12612-bib-0030){ref-type="ref"}; rs7901695[18](#jdi12612-bib-0018){ref-type="ref"}, [20](#jdi12612-bib-0020){ref-type="ref"}, [25](#jdi12612-bib-0025){ref-type="ref"}, [29](#jdi12612-bib-0029){ref-type="ref"}, [31](#jdi12612-bib-0031){ref-type="ref"}; rs290487[28](#jdi12612-bib-0028){ref-type="ref"}, [32](#jdi12612-bib-0032){ref-type="ref"}, [33](#jdi12612-bib-0033){ref-type="ref"}; rs11196205[28](#jdi12612-bib-0028){ref-type="ref"}, [32](#jdi12612-bib-0032){ref-type="ref"}; rs11196218[32](#jdi12612-bib-0032){ref-type="ref"}, [34](#jdi12612-bib-0034){ref-type="ref"}; rs12243326[25](#jdi12612-bib-0025){ref-type="ref"}, [29](#jdi12612-bib-0029){ref-type="ref"}; and rs4506565.[25](#jdi12612-bib-0025){ref-type="ref"}, [29](#jdi12612-bib-0029){ref-type="ref"} The SNP rs7903146 has been most widely researched, and has been associated with an increased risk of GDM in Scandinavian women[7](#jdi12612-bib-0007){ref-type="ref"}. A study of Mexican Americans showed that SNP rs12255372 of *TCF7L2* has a relationship with GDM risk and affected the insulin response to oral glucose in propends with GDM[30](#jdi12612-bib-0030){ref-type="ref"}, and rs7901695 has been shown to benefit individuals with type 2 diabetes mellitus and GDM risk[18](#jdi12612-bib-0018){ref-type="ref"}. The SNPs rs7903146 C\>T, rs12255372 G\>T and rs7901695 T\>C are the strongest to be beneficial to GDM risk[35](#jdi12612-bib-0035){ref-type="ref"}, and lie within a well‐defined linkage disequilibrium block[36](#jdi12612-bib-0036){ref-type="ref"}, [37](#jdi12612-bib-0037){ref-type="ref"}, [38](#jdi12612-bib-0038){ref-type="ref"}. A study has also shown that SNPs were susceptible to type 2 diabetes mellitus occurrence through damaging insulin secretion, possibly attributable to a potential mechanism in β‐cells[39](#jdi12612-bib-0039){ref-type="ref"}. The other five SNPs have been less studied, and conflicting findings exist. Furthermore, individual studies might be limited by relatively inadequate sample sizes, and might be unable to receive convincing results. Therefore, we carried out a meta‐analysis to examine the association between *TCF7L2* polymorphisms and the risk of GDM.

Materials and Methods {#jdi12612-sec-0006}
=====================

Literature search {#jdi12612-sec-0007}
-----------------

A retrieve was carried out for related available articles published in four databases including PubMed and EMBASE for English articles, and China National Knowledge Infrastructure and Wanfang for Chinese articles. '*TCF7L2*', 'transcription factor 7‐like 2', 'polymorphism', 'SNP', 'GDM', 'gestational diabetes mellitus', 'Gestational diabetes' and 'Screening for gestational diabetes' as keywords were used to search. We also evaluated the references in the retrieved studies, and recognized extra‐published articles not captured in review articles by search strategy from these databases.

Inclusion criteria {#jdi12612-sec-0008}
------------------

The following was the inclusion criteria, including: (i) case--control or cohort study published as an original study to assess the relationship between *TCF7L2* polymorphisms with GDM risk; (ii) precise numbers for each genotype reported in case and control groups or exposed and unexposed groups, or countable data from these numbers in the published papers; and (iii) participants from the same ethnicity and the same time in each research; and (iv) the nearest and integrated article was selected if a paper had been published more than once.

Data extraction {#jdi12612-sec-0009}
---------------

According to the inclusion criteria listed above, information was drawn from all eligible papers by two reviewers (Chang Shaoyan and Wang Zhen) independently, and the validation was tested by a third reviewer if there was disagreement. The literature were eliminated as follows: overviews or editorials, studies with cell culture or animal research, studies based on family, studies of the primary outcome exclusive of GDM, and studies with no evaluation of the relationships of GDM and *TCF7L2* polymorphisms, and studies that excluded a quality control group, or insufficient data for influence evaluations of the genetic relationships. Data were drawn from each published article as follows: first author, publication year, ethnicity, country, mean age, genotyping method, size of sample, number of cases and controls, study design, genetic variants, minor allele and allele distribution by GDM situation. If odds ratios (ORs) were accessible, but the genotype and allele distributions on the basis of GDM situation were not covered in the primitive study, the corresponding authors were contacted by email.

Quality assessment {#jdi12612-sec-0010}
------------------

Risk of bias was devoted to evaluate the methodological reliability of the incorporated studies. Quality was accessed based on five questions, using different colors for low risk (green), unclear risk (yellow), and high risk (read), with more green manifesting better research quality.

Statistical analysis {#jdi12612-sec-0011}
--------------------

A meta‐analysis was carried out by RevMan version 5.2 (Cochrane Collaboration, Oxford, UK) and Stata13 software (StataCorp, College Station, Texas, USA). During the data analysis, we carried out independent meta‐analyses for GDM and *TCF7L2* variants. The ORs of individual research were recounted from the accessible genotype distributions based on an allelic model, pooled using random‐effects models (REMs) or fixed‐effect models (FEMs) and visualized using forest plots. Heterogeneity in all qualified comparisons was evaluated by the *I* ^2^‐value and the χ^2^‐test to evaluate the *P*‐value. *I* ^2^ was the percentage of total degree of variation observed among the studies due to actual differences between the trials rather than to sampling error (chance), where *I* ^2^ \> 50% is regarded as a significant heterogeneity.

Results {#jdi12612-sec-0012}
=======

Description of the included studies {#jdi12612-sec-0013}
-----------------------------------

The search generated 147 articles of which 21 were eligible for meta‐analysis (Figure [1](#jdi12612-fig-0001){ref-type="fig"}). The 22 eligible studies captured eight *TCF7L2* SNPs, and included 5,573 cases and 13,266 controls. There were 18 studies about rs7903146, 10 about rs12255372, 5 about rs7901695, 3 about rs290487, 2 about rs11196205, 2 about rs11196218, 2 about rs12243326 and 2 about rs4506565. Characteristics of the included studies, and the genotype and allele distributions of SNPs among GDM cases and controls are shown in Tables [1](#jdi12612-tbl-0001){ref-type="table-wrap"} and [2](#jdi12612-tbl-0002){ref-type="table-wrap"}.

![Selection of studies for inclusion in the meta‐analysis.](JDI-8-560-g001){#jdi12612-fig-0001}

###### 

Characteristics of the included studies on the association between *TCF7L2* and gestational diabetes mellitus risk

  Author, (year) reference                                         Ethnicity          Country            Mean age (cases/controls)   Genotyping method                     GDM criteria
  ---------------------------------------------------------------- ------------------ ------------------ --------------------------- ------------------------------------- --------------
  Aris, (2012)[27](#jdi12612-bib-0027){ref-type="ref"}             Asian              Malaysia           29.7/28.5                   NA                                    ADA
  Cho, (2009)[17](#jdi12612-bib-0017){ref-type="ref"}              Asian              Korea              32/64.7                     Allelic discrimination assay          IWCGDM
  de Melo, (2015)[26](#jdi12612-bib-0026){ref-type="ref"}          Hispanic/Latino    Brazil             32/24                       SNP Genotyping Assay                  ADA
  Freathy, (2010)[12](#jdi12612-bib-0012){ref-type="ref"}          Mixed              Australia and UK   NA                          Illumina Golden Gate platform         OGTT
  Kan, (2014)[15](#jdi12612-bib-0015){ref-type="ref"}              Asian              China              30.7/30.9                   Allelic discrimination assay          OGTT
  Huerta‐Chagoya, (2015)[25](#jdi12612-bib-0025){ref-type="ref"}   Hispanic/Latino    Mexico             35/28                       SNP genotype (LGC)                    OGTT
  Hui, (2011)[32](#jdi12612-bib-0032){ref-type="ref"}              Asian              China              32/30                       PCR‐LDR                               OGTT
  Klein, (2012)[19](#jdi12612-bib-0019){ref-type="ref"}            Caucasian          Australia          28.2/30.1                   NA                                    OGTT
  Liu, (2014)[33](#jdi12612-bib-0033){ref-type="ref"}              Asian              China              31.88/28.78                 Mass spectrometry                     OGTT
  Pagan, (2014)[29](#jdi12612-bib-0029){ref-type="ref"}            Caucasian          Spain              34.31/31.2                  Sequencing                            OGTT
  Papadopoulou, (2011)[20](#jdi12612-bib-0020){ref-type="ref"}     Caucasian          Sweden             NA                          TaqMan allelic discrimination assay   OGTT
  Reyes‐López, (2014)[21](#jdi12612-bib-0021){ref-type="ref"}      Mexican            Mexico             29/31                       PCR                                   ADA
  RIZK, (2011)[16](#jdi12612-bib-0016){ref-type="ref"}             Caucasian          Qatar              NA                          TaqMan allelic discrimination assay   NA
  Shaat, (2007)[14](#jdi12612-bib-0014){ref-type="ref"}            Caucasian          Scandinavia        32.3/30.5                   TaqMan allelic discrimination assay   OGTT
  Shi, (2014)[28](#jdi12612-bib-0028){ref-type="ref"}              Asian              China              30/29                       AS‐PCR                                OGTT
  Stuebe, (2014)[31](#jdi12612-bib-0031){ref-type="ref"}           African‐American   USA                24.1 (total)                Sequenom iPLEX platform               OGTT
  Thomas, (2014)[24](#jdi12612-bib-0024){ref-type="ref"}           Asian              India              NA                          NA                                    NA
  Vcelak, (2012)[18](#jdi12612-bib-0018){ref-type="ref"}           Caucasian          Czech Republic     32.8/29.9                   TaqMan allelic discrimination assay   WHO
  Wang, (2013)[39](#jdi12612-bib-0039){ref-type="ref"}             Asian              China              NA                          PCR‐LDR                               OGTT
  Watanabe, (2007)[30](#jdi12612-bib-0030){ref-type="ref"}         Mexican‐American   USA                35.0/33.4                   TaqMan allelic discrimination assay   OGTT
  Zhang, (2015)[23](#jdi12612-bib-0023){ref-type="ref"}            Asian              China              30.58/28.75                 PCR‐RFLP                              OGTT

ADA, American Diabetes Association; AS‐PCR, allele‐specific polymerase chain reaction; GDM, gestational diabetes mellitus; IWCGDM, International Workshop‐Conference on Gestational Diabetes Mellitus; LGC, LGC Bioresearch Technologies; OGTT, oral glucose tolerance test; NA, not available; PCR, polymerase chain reaction; PCR‐LDR, ligase detection reaction--polymerase chain reaction; SNP, single nucleotide polymorphism; WHO, World Health Organization.
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###### 

*TCF7L2* allele distribution among GDM cases and controls in the included studies

  Author (year)           Variant (minor allele)   No. cases   Genotypes in GDM case   Genotypes in GDM control   Minor allele frequency (%)   *P* for HWE                                            
  ----------------------- ------------------------ ----------- ----------------------- -------------------------- ---------------------------- ------------- ------- ------- ------- ------- -------- --------
  Aris (2012)             rs7903146(T)             173         114                     129                        43                           1             99      15      0       87      93.4     0.686
  Cho (2009)              868                      627         2                       63                         803                          0             31      596     3.9     2.5     1        
  de Melo (2015)          200                      200         20                      104                        76                           16            86      98      36      29.5    0.633    
  Freathy (2010)          614                      3,811       75                      246                        293                          370           1,557   1,884   32.2    30.1    0.29     
  Freathy (2010)          384                      1,332       0                       46                         338                          3             108     1,211   6       4.3     0.73     
  Huerta‐Chagoya (2015)   408                      342         19                      124                        265                          10            67      265     19.9    12.7    0.03     
  Kan (2014)              100                      100         1                       15                         84                           0             5       95      8.5     5       \>0.05   
  Klein (2012)            125                      125         5                       112                        8                            8             107     10      48.8    49.2    NA       
  Lauenborg (2009)        276                      2,353       33                      125                        118                          198           863     1,292   34.6    26.8    \>0.05   
  Pagan (2014)            45                       24          8                       18                         19                           2             12      10      38      33      1        
  Papadopoulou (2011)     803                      1,110       88                      352                        363                          82            384     644     32.9    24.7    0.02     
  PAPPA (2011)            148                      107         18                      81                         49                           7             38      62      39.53   24.29   0.792    
  Reyes‐López (2014)      90                       108         6                       29                         55                           4             23      81      23      14      NA       
  RIZK (2011)             40                       74          6                       18                         16                           8             37      29      37.5    37.2    0.706    
  Shaat (2007)            585                      1,111       59                      255                        271                          69            392     650     31.9    23.8    0.363    
  Shi (2014)              100                      100         24                      36                         40                           7             38      55      42      26      \>0.05   
  Thomas (2014)           117                      49          16                      46                         55                           4             18      27      33.3    26.5    0.452    
  Vcelak (2012)           261                      376         17                      102                        142                          35            185     156     33.8    26.1    0.067    
  Zhang (2015)            113                      115         0                       17                         96                           0             5       110     7.52    2.17    \>0.05   
  Cho (2009)              rs12255372(T)            867         630                     0                          7                            860           0       2       628     0.4     0.2      NA
  de Melo (2015)          200                      200         20                      88                         92                           23            75      102     32      30.3    0.633    
  Klein (2012)            125                      125                                                                                                                       39.6    28      NA       
  Pagan (2014)            45                       25          6                       20                         19                           2             14      9       36      36      0.4095   
  Papadopoulou (2011)     801                      1,102       81                      333                        387                          84            385     633     30.9    25.1    0.02     
  Reyes‐López (2014)      90                       108         7                       23                         60                           2             5       101     20      5       NA       
  RIZK (2011)             40                       74          6                       28                         6                            11            38      25      50      40.5    0.108    
  Shi (2014)              100                      100         0                       0                          100                          0             0       100     0       0       \>0.05   
  Vcelak (2012)           260                      376         22                      115                        124                          23            147     206     30      25.7    0.067    
  Watanabe (2007)         94                       58                                                                                                                        39.4    20.7    NA       
  Huerta‐Chagoya (2015)   rs7901695(C)             408         342                     NA                         NA                           NA            NA      NA      NA      20.3    13.6     0.03
  Pagan (2014)            45                       25          8                       20                         17                           2             13      10      40      34      0.6626   
  Papadopoulou (2011)     794                      1,102       95                      356                        343                          90            405     607     34.4    26.5    0.02     
  Stuebe (2014)           56                       842         9                       30                         17                           70            357     415     42.9    29.5    \>0.05   
  Stuebe (2014)           24                       366         4                       15                         5                            79            162     121     47.9    43.7    \>0.05   
  Vcelak (2012)           261                      376         25                      130                        106                          24            147     205     34.4    26.9    0.067    
  Hui (2011)              rs290487(C)              480         631                     90                         220                          170           88      282     261     41.7    36.3     0.2076
  Shi (2014)              100                      90          12                      36                         52                           6             34      50      30      33      \>0.05   
  Wang (2013)             70                       70          11                      37                         22                           9             33      28      42.2    36.5    NA       
  Hui (2011)              rs11196205(G)            479         623                     461                        18                           0             591     32      0       98.1    97.4     1
  Shi (2014)              100                      100         99                      0                          1                            100           0       0       99      100     \>0.05   
  Hui (2011)              rs11196218(A)            471         625                     30                         201                          240           43      256     326     27.7    27.4     0.1449
  Liu (2014)              144                      144         9                       58                         77                           5             53      86      26      22      \>0.05   
  Huerta‐Chagoya (2015)   rs12243326(C)            408         342                     NA                         NA                           NA            NA      NA      NA      16.8    9.6      0.03
  Pagan (2014)            45                       25          7                       20                         18                           2             13      10      38      34      0.6626   
  Huerta‐Chagoya (2015)   rs4506565(T)             408         342                     NA                         NA                           NA            NA      NA      NA      21.3    14       0.03
  Pagan (2014)            45                       25          9                       20                         16                           0             12      13      42      24      0.2762   

GDM, gestational diabetes mellitus; HWE, Hardy--Weinberg equilibrium; NA, not available.
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Meta‐analysis results {#jdi12612-sec-0014}
---------------------

The SNP rs7903146 of *TCF7L2* was the most extensively studied variant, and showed a conflicting correlation across different populations. The results of the allele distribution are described in detail in Table [2](#jdi12612-tbl-0002){ref-type="table-wrap"}. We found a significant correlation between the T allele of SNP rs7903146 and the risk of GDM (REM, OR 1.36, 95% CI: 1.17--1.57) by meta‐analysis. Further subgroup analyses were carried out based on race/ethnicity, and the results showed significant relationships in all populations including in Caucasian (REM, OR 1.27, 95% CI: 1.04--1.55), Asian (REM, OR 1.55, 95% CI: 1.05--2.31) and other populations (REM, OR1.39, 95% CI: 1.08--1.80; Figure [2](#jdi12612-fig-0002){ref-type="fig"}).

![Forest plots of the relationship between *TCF7L2* rs7903146 polymorphism and the risk of gestational diabetes mellitus across different populations. Black diamonds denote the pooled odds ratio. Blue squares indicate the odds ratio in each study, with square sizes inversely proportional to the standard error of the odds ratio. Horizontal lines represent 95% confidence intervals (CI).](JDI-8-560-g002){#jdi12612-fig-0002}

The rs12255372 polymorphism was also widely studied with the results of different relationships with GDM risk in different populations. There was a significant relationship between the T allele of SNP rs12255372 and the risk of GDM (REM, OR 1.55, 95% CI: 1.23--1.96) by meta‐analysis. Further subgroup analyses showed significant correlations in Caucasian (REM, OR 1.32, 95% CI: 1.17--1.48) and other populations (REM, OR 2.11, 95% CI: 1.17--3.82), but no correlation in Asian populations (REM, OR 2.55, 95% CI: 0.53--12.29; Figure [3](#jdi12612-fig-0003){ref-type="fig"}).

![Forest plots of the relationship between *TCF7L2* rs12255372 polymorphism and the risk of gestational diabetes mellitus across different populations. Black diamonds denote the pooled odds ratio. Blue squares indicate the odds ratio in each study, with square sizes inversely proportional to the standard error of the odds ratio. Horizontal lines represent 95% confidence intervals (CI).](JDI-8-560-g003){#jdi12612-fig-0003}

Additionally, a significant relationship was discovered between the C allele of SNP rs7901695 and GDM risk by meta‐analysis with 1.49 (95% CI: 1.34--1.66) of overall OR (FEM). Further subgroup analyses showed significant correlations in Caucasian (FEM, OR 1.48, 95% CI: 1.32--1.66) and other populations (FEM, OR 1.53, 95% CI: 1.19--1.97; Figure [4](#jdi12612-fig-0004){ref-type="fig"}).

![Forest plots of the relationship between *TCF7L2* rs7901695 polymorphism and the risk of gestational diabetes mellitus across different populations. Black diamonds denote the pooled odds ratio. Blue squares indicate the odds ratio in each study, with square sizes inversely proportional to the standard error of the odds ratio. Horizontal lines represent 95% confidence intervals (CI).](JDI-8-560-g004){#jdi12612-fig-0004}

Three variants in the *TCF7L2* gene, including rs290487, rs11196205 and rs11196218, were researched only in Chinese populations (Figures [5](#jdi12612-fig-0005){ref-type="fig"}, [6](#jdi12612-fig-0006){ref-type="fig"}, [7](#jdi12612-fig-0007){ref-type="fig"}). There was a significant correlation between rs290487 (FEM, OR 1.25, 95% CI: 1.08--1.46) and GDM risk, but no correlation with rs11196205 (FEM, OR 1.24, 95% CI: 0.71--2.18) and rs11196218 (FEM, OR 1.06, 95% CI: 0.90--1.26). Two other SNPs in the *TCF7L2* gene were found only in two literature research articles with different ethnicity, and they had significant correlations between rs4506565 (FEM, OR 1.72, 95% CI: 1.33--2.23) with GDM, and rs12243326 (FEM, OR 1.76, 95% CI: 1.32--2.34) with GDM (Figures [8](#jdi12612-fig-0008){ref-type="fig"} and [9](#jdi12612-fig-0009){ref-type="fig"}).

![Forest plots of the relationship between *TCF7L2* rs290487 polymorphism and the risk of gestational diabetes mellitus across different populations. Black diamonds denote the pooled odds ratio. Blue squares indicate the odds ratio in each study, with square sizes inversely proportional to the standard error of the odds ratio. Horizontal lines represent 95% confidence intervals (CI).](JDI-8-560-g005){#jdi12612-fig-0005}

![Forest plots of the relationship between *TCF7L2* rs11196205 polymorphism and the risk of gestational diabetes mellitus across different populations. Black diamonds denote the pooled odds ratio. Blue squares indicate the odds ratio in each study, with square sizes inversely proportional to the standard error of the odds ratio. Horizontal lines represent 95% confidence intervals (CI).](JDI-8-560-g006){#jdi12612-fig-0006}

![Forest plots of the relationship between *TCF7L2* rs11196218 polymorphism and risk of gestational diabetes mellitus (GDM) across different populations. Black diamonds denote the pooled odds ratio. Blue squares indicate the odds ratio in each study, with square sizes inversely proportional to the standard error of the odds ratio. Horizontal lines represent 95% confidence intervals (CI).](JDI-8-560-g007){#jdi12612-fig-0007}

![Forest plots of the relationship between *TCF7L2* rs4506565 polymorphism and the risk of gestational diabetes mellitus (GDM) across different populations. Black diamonds denote the pooled odds ratio. Blue squares indicate the odds ratio in each study, with square sizes inversely proportional to the standard error of the odds ratio. Horizontal lines represent represent 95% confidence intervals (CI).](JDI-8-560-g008){#jdi12612-fig-0008}

![Forest plots of the relationship between *TCF7L2* rs12243326 polymorphism and risk of gestational diabetes mellitus across different populations. Black diamonds denote the pooled odds ratio. Blue squares indicate the odds ratio in each study, with square sizes inversely proportional to the standard error of the odds ratio. Horizontal lines represent 95% confidence intervals (CI).](JDI-8-560-g009){#jdi12612-fig-0009}

Heterogeneity {#jdi12612-sec-0015}
-------------

Heterogeneity between studies was measured in all comparisons. There was no heterogeneity in rs7901695, rs4506565 and rs290487 with *I* ^2^ = 0%, slight heterogeneity in rs11196205 (*I* ^2^ = 34%), rs11196218 (*I* ^2^ = 10%) and rs12243326 (*I* ^2^ = 27%), but severe heterogeneity in rs12255372 (*I* ^2^ = 67%) and rs7903146 (*I* ^2^ = 77%). Except for rs12255372 and rs7903146, all SNPs in the *TCF7L2* gene were analyzed using the FEM. Although subgroup analysis according to ethnicity of rs12255372 and rs7903146 was carried out, heterogeneity was still severe. Therefore, the use of REMs was justified in these analyses.

Publication bias analysis {#jdi12612-sec-0016}
-------------------------

Publication bias of all *TCF7L2* SNPs was determined using a funnel plot of Revman 5.2, but vague results of SNPs rs7903146 and SNPs rs7903146 were found. Therefore, Egger of Stata13 was used to further confirm the results. The results showed that no evidence of statistically significant publication bias was detected for the studies (Figure [\[Link\]](#jdi12612-sup-0001){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0002){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0003){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0004){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0005){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0006){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0007){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0008){ref-type="supplementary-material"}; Tables [\[Link\]](#jdi12612-sup-0009){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0010){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0011){ref-type="supplementary-material"}, [\[Link\]](#jdi12612-sup-0012){ref-type="supplementary-material"}).

Discussion {#jdi12612-sec-0017}
==========

An increasing number of studies have shown that *TCF7L2* variants are related to GDM risk. However, the results of the studies are inconsistent and incomplete, and might have limited statistical power with individual studies having relatively small sample sizes and the analysis of partial SNPs. Therefore, we carried out the meta‐analysis with the aim to provide a more comprehensive summary of the currently available evidence with respect to the relationship between *TCF7L2* variants and GDM risk. Overall, 22 eligible studies captured eight *TCF7L2* SNPs*,* including 5,573 cases and 13,266 controls. The SNPs rs7903146 C\>T, rs12255372 G\>T and rs7901695 T\>C were the most powerful to assess the relationship between *TCF7L2* polymorphism and the risk of GDM. The SNPs rs7903146 and rs7901695 showed significant relationships with GDM risk in the overall and subgroup analyses; however, the relationship of rs12255372 was significant and conflicting among different ethnicities.

GDM can progress when a genetic susceptibility to pancreatic islet β‐cell injury is exposed by incremental insulin resistance during pregnancy[40](#jdi12612-bib-0040){ref-type="ref"}. Among the most widely studied genes involved in GDM risk, *TCF7L2* is identified as regulating β‐cell action[41](#jdi12612-bib-0041){ref-type="ref"}. It is well known that *TCF7L2* expresses in pancreatic β‐cells, and belongs to the supernal mobility group‐box transcription factors family and plays a vital role in maintaining glucose homeostasis. Eight SNPs in the *TCF7L2* gene have been reported, including rs7903146, rs12255372, rs7901695, rs290487, rs4506565, rs11196205, rs11196218 and rs12243326.

The most widely studied SNP was rs7903146, and a previous meta‐analysis regarding this SNP found a 1.65‐fold increased risk of GDM, based on six studies[42](#jdi12612-bib-0042){ref-type="ref"}, and 1.63‐fold in 16 studies[43](#jdi12612-bib-0043){ref-type="ref"}. We identified 18 studies assessing the association, and the results were consistent with the previous analysis. Furthermore, we carried out subgroup analysis based on ethnicity, and found a significant correlation in Caucasian and Asian ethnicities and others, as seen in the previous study. Combined with all results, T allele of the SNP rs7903146 of *TCF7L2* was related to GDM risk.

The rs12255372 variant was also widely studied with the results of different relationships with GDM risk in different populations. A systematic review of four studies found a significant relationship between this SNP and GDM[44](#jdi12612-bib-0044){ref-type="ref"}. We extended the sample to nine studies, and increased the number of participants to carry out a relatively comprehensive assessment. The significant relationship remained, with rs12255372 associated with GDM, consistent with previous research. However, findings of the subgroup analysis differed, with a significant correlation in Caucasian and other groups, but no association in Asian groups. Overall, this suggests that the T allele of rs12255372 might be related to GDM risk, but to varying degrees among different ethnicities.

A significant relationship was discovered in the meta‐analysis regarding the C allele of rs7901695 and the risk of GDM (OR 1.49, 95% CI: 1.34--1.66), with subgroup analysis showing a significant correlation in Caucasian, Asian and other groups.

In conclusion, different relationships between *TCF7L2* variants and GDM risk among different ethnic groups might be attributable to genetic characteristics and sample size, or selection standards of participants, but could also be because of different growth environments, body structure and variations in genetic background. Therefore, ongoing research and systematic analysis is important. Because we were unable to completely eliminate potential bias and heterogeneous factors in the present meta‐analysis, further studies with rich sample capacity and using normalized unbiased genotyping methods are required to verify the present findings.
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**Figure S1 \|** Funnel plots of publication bias for the relationship of *TCF7L2* rs7903146 polymorphism and risk of gestational diabetes mellitus across different populations.
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Click here for additional data file.
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**Figure S2 \|** Funnel plots of publication bias for the relationship of *TCF7L2* rs12255372 polymorphism and risk of gestational diabetes mellitus across different populations.
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**Figure S3 \|** Funnel plots of publication bias for the relationship of *TCF7L2* rs7901695 polymorphism and risk of gestational diabetes mellitus across different populations.
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**Figure S4 \|** Funnel plots of publication bias for the relationship of *TCF7L2* rs290487 polymorphism and risk of gestational diabetes mellitus across different populations.
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Click here for additional data file.
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**Figure S5 \|** Funnel plots of publication bias for the relationship of *TCF7L2* rs4506565 polymorphism and risk of gestational diabetes mellitus across different populations.

###### 

Click here for additional data file.
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**Figure S6 \|** Funnel plots of publication bias for the relationship of *TCF7L2* rs11196205 polymorphism and risk of gestational diabetes mellitus across different populations.
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**Figure S7 \|** Funnel plots of publication bias for the relationship of *TCF7L2* rs11196218 polymorphism and risk of gestational diabetes mellitus across different populations.
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**Figure S8 \|** Funnel plots of publication bias for the relationship of *TCF7L2* rs12243326 polymorphism and risk of gestational diabetes mellitus across different populations.
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Click here for additional data file.

###### 

**Table S1 \|** Publication bias list for the relationship of *TCF7L2* rs7903146 polymorphism and risk of GDM across different populations.
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**Table S2 \|** Egger\'s test of publication bias for the relationship of *TCF7L2* rs7903146 polymorphism and risk of GDM across different populations.

###### 

Click here for additional data file.
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**Table S3 \|** Publication bias list for the relationship of *TC*F7L2 rs12255372 polymorphism and risk of GDM across different populations.
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**Table S4 \|** Egger\'s test of publication bias for the relationship of *T*CF7L2 rs12255372 polymorphism and risk of GDM across different populations.
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Click here for additional data file.
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